Literature DB >> 23892749

Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve.

Santiago Ruiz-Moyano1, Sarah M Totten, Daniel A Garrido, Jennifer T Smilowitz, J Bruce German, Carlito B Lebrilla, David A Mills.   

Abstract

Human milk contains a high concentration of complex oligosaccharides that influence the composition of the intestinal microbiota in breast-fed infants. Previous studies have indicated that select species such as Bifidobacterium longum subsp. infantis and Bifidobacterium bifidum can utilize human milk oligosaccharides (HMO) in vitro as the sole carbon source, while the relatively few B. longum subsp. longum and Bifidobacterium breve isolates tested appear less adapted to these substrates. Considering the high frequency at which B. breve is isolated from breast-fed infant feces, we postulated that some B. breve strains can more vigorously consume HMO and thus are enriched in the breast-fed infant gastrointestinal tract. To examine this, a number of B. breve isolates from breast-fed infant feces were characterized for the presence of different glycosyl hydrolases that participate in HMO utilization, as well as by their ability to grow on HMO or specific HMO species such as lacto-N-tetraose (LNT) and fucosyllactose. All B. breve strains showed high levels of growth on LNT and lacto-N-neotetraose (LNnT), and, in general, growth on total HMO was moderate for most of the strains, with several strain differences. Growth and consumption of fucosylated HMO were strain dependent, mostly in isolates possessing a glycosyl hydrolase family 29 α-fucosidase. Glycoprofiling of the spent supernatant after HMO fermentation by select strains revealed that all B. breve strains can utilize sialylated HMO to a certain extent, especially sialyl-lacto-N-tetraose. Interestingly, this specific oligosaccharide was depleted before neutral LNT by strain SC95. In aggregate, this work indicates that the HMO consumption phenotype in B. breve is variable; however, some strains display specific adaptations to these substrates, enabling more vigorous consumption of fucosylated and sialylated HMO. These results provide a rationale for the predominance of this species in breast-fed infant feces and contribute to a more accurate picture of the ecology of the developing infant intestinal microbiota.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23892749      PMCID: PMC3811376          DOI: 10.1128/AEM.01843-13

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  39 in total

1.  Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract.

Authors:  M B Engfer; B Stahl; B Finke; G Sawatzki; H Daniel
Journal:  Am J Clin Nutr       Date:  2000-06       Impact factor: 7.045

2.  Development: Mother's milk: A rich opportunity.

Authors:  Anna Petherick
Journal:  Nature       Date:  2010-12-23       Impact factor: 49.962

3.  Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging.

Authors:  Francesca Turroni; Francesca Bottacini; Elena Foroni; Imke Mulder; Jae-Han Kim; Aldert Zomer; Borja Sánchez; Alessandro Bidossi; Alberto Ferrarini; Vanessa Giubellini; Massimo Delledonne; Bernard Henrissat; Pedro Coutinho; Marco Oggioni; Gerald F Fitzgerald; David Mills; Abelardo Margolles; Denise Kelly; Douwe van Sinderen; Marco Ventura
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

4.  16S ribosomal DNA amplification for phylogenetic study.

Authors:  W G Weisburg; S M Barns; D A Pelletier; D J Lane
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

Review 5.  Human milk glycans protect infants against enteric pathogens.

Authors:  David S Newburg; Guillermo M Ruiz-Palacios; Ardythe L Morrow
Journal:  Annu Rev Nutr       Date:  2005       Impact factor: 11.848

6.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

7.  Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life.

Authors:  Laure C Roger; Adele Costabile; Diane T Holland; Lesley Hoyles; Anne L McCartney
Journal:  Microbiology       Date:  2010-09-23       Impact factor: 2.777

8.  Human milk oligosaccharides are minimally digested in vitro.

Authors:  M J Gnoth; C Kunz; E Kinne-Saffran; S Rudloff
Journal:  J Nutr       Date:  2000-12       Impact factor: 4.798

9.  Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation.

Authors:  P Chaturvedi; C D Warren; M Altaye; A L Morrow; G Ruiz-Palacios; L K Pickering; D S Newburg
Journal:  Glycobiology       Date:  2001-05       Impact factor: 4.313

10.  Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization.

Authors:  Riccardo G LoCascio; Prerak Desai; David A Sela; Bart Weimer; David A Mills
Journal:  Appl Environ Microbiol       Date:  2010-08-27       Impact factor: 4.792

View more
  90 in total

Review 1.  Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant.

Authors:  Kannikar Vongbhavit; Mark A Underwood
Journal:  Clin Ther       Date:  2016-02-09       Impact factor: 3.393

2.  Biochemical characterization of Helicobacter pylori α1-3-fucosyltransferase and its application in the synthesis of fucosylated human milk oligosaccharides.

Authors:  Jing Bai; Zhigang Wu; Go Sugiarto; Madhusudhan Reddy Gadi; Hai Yu; Yanhong Li; Cong Xiao; Alice Ngo; Baohua Zhao; Xi Chen; Wanyi Guan
Journal:  Carbohydr Res       Date:  2019-05-16       Impact factor: 2.104

3.  Synthesis of lacto-N-tetraose.

Authors:  Kelly M Craft; Steven D Townsend
Journal:  Carbohydr Res       Date:  2017-02-11       Impact factor: 2.104

Review 4.  Breast milk oligosaccharides: structure-function relationships in the neonate.

Authors:  Jennifer T Smilowitz; Carlito B Lebrilla; David A Mills; J Bruce German; Samara L Freeman
Journal:  Annu Rev Nutr       Date:  2014-05-15       Impact factor: 11.848

5.  Infant Maturity at Birth Reveals Minor Differences in the Maternal Milk Metabolome in the First Month of Lactation.

Authors:  Ann R Spevacek; Jennifer T Smilowitz; Elizabeth L Chin; Mark A Underwood; J Bruce German; Carolyn M Slupsky
Journal:  J Nutr       Date:  2015-06-03       Impact factor: 4.798

6.  Fecal metatranscriptomics and glycomics suggest that bovine milk oligosaccharides are fully utilized by healthy adults.

Authors:  Samuel T Westreich; Jaime Salcedo; Blythe Durbin-Johnson; Jennifer T Smilowitz; Ian Korf; David A Mills; Daniela Barile; Danielle G Lemay
Journal:  J Nutr Biochem       Date:  2020-01-17       Impact factor: 6.048

7.  A novel endo-β-N-acetylglucosaminidase releases specific N-glycans depending on different reaction conditions.

Authors:  Annabelle Le Parc; Sercan Karav; Juliana Maria Leite Nobrega De Moura Bell; Steven A Frese; Yan Liu; David A Mills; David E Block; Daniela Barile
Journal:  Biotechnol Prog       Date:  2015-07-04

8.  Oligosaccharides Released from Milk Glycoproteins Are Selective Growth Substrates for Infant-Associated Bifidobacteria.

Authors:  Sercan Karav; Annabelle Le Parc; Juliana Maria Leite Nobrega de Moura Bell; Steven A Frese; Nina Kirmiz; David E Block; Daniela Barile; David A Mills
Journal:  Appl Environ Microbiol       Date:  2016-05-31       Impact factor: 4.792

9.  Metabolism of sialic acid by Bifidobacterium breve UCC2003.

Authors:  Muireann Egan; Mary O'Connell Motherway; Marco Ventura; Douwe van Sinderen
Journal:  Appl Environ Microbiol       Date:  2014-05-09       Impact factor: 4.792

Review 10.  Lactation and Intestinal Microbiota: How Early Diet Shapes the Infant Gut.

Authors:  Felicia Goldsmith; Aifric O'Sullivan; Jennifer T Smilowitz; Samara L Freeman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-07-31       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.